We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
-0.82%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.61B
AUM Growth
+$447M
Cap. Flow
+$533M
Cap. Flow %
33.15%
Top 10 Hldgs %
11.86%
Holding
2,259
New
642
Increased
549
Reduced
466
Closed
595

Top Buys

Rank Stock Value
1
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$39.8M
2
VCIT icon
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
+$32.6M
3
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$28.3M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$23.1M
5
IGSB icon
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
+$19.9M

Top Sells

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$4.13M
2
NVDA icon
NVIDIA
NVDA
+$4.12M
3
PFE icon
Pfizer
PFE
+$4.01M
4
LNG icon
Cheniere Energy
LNG
+$3.83M
5
HOLX
Hologic
HOLX
+$3.1M

Sector Composition

Rank Sector Weight
1 Financials 13.44%
2 Technology 13.16%
3 Healthcare 12.56%
4 Industrials 12.44%
5 Consumer Discretionary 10.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MAA icon
451
Mid-America Apartment Communities
MAA
$15.6B
$1.08M 0.07%
8,857
+6,187
+232% +$817K
TNET icon
452
TriNet
TNET
$2.84B
$1.08M 0.07%
29,699
+18,872
+174% +$901K
ASLE icon
453
AerSale
ASLE
$292M
$1.08M 0.07%
173,625
+7,832
+5% +$55.9K
PHAT icon
454
Phathom Pharmaceuticals
PHAT
$912M
$1.08M 0.07%
97,068
+14,444
+17% +$182K
AZTA icon
455
Azenta
AZTA
$1.26B
$1.08M 0.07%
50,949
-6,782
-12% -$203K
WKC icon
456
World Kinect Corp
WKC
$1.96B
$1.07M 0.07%
46,565
-50,209
-52% -$1.27M
EDIT icon
457
Editas Medicine
EDIT
$399M
$1.07M 0.07%
434,413
-134,396
-24% -$284K
REAL icon
458
The RealReal
REAL
$1.34B
$1.07M 0.07%
117,877
+11,534
+11% +$146K
GOSS icon
459
Gossamer Bio
GOSS
$66.5M
$1.07M 0.07%
3,254,233
+3,202,373
+6,175% +$5.03M
RLI icon
460
RLI Corp
RLI
$5.68B
$1.07M 0.07%
18,712
-3,306
-15% -$199K
ADMA icon
461
ADMA Biologics
ADMA
$1.92B
$1.06M 0.07%
+118,034
New +$1.86M
NTES icon
462
NetEase
NTES
$76.5B
$1.06M 0.07%
+9,486
New +$1.18M
CART icon
463
Maplebear
CART
$9.92B
$1.06M 0.07%
28,295
+12,427
+78% +$471K
INGN icon
464
Inogen
INGN
$167M
$1.06M 0.07%
171,440
+85,572
+100% +$528K
TIGR
465
UP Fintech Holding
TIGR
$845M
$1.06M 0.07%
168,137
+119,738
+247% +$975K
AMAT icon
466
Applied Materials
AMAT
$426B
$1.05M 0.07%
3,084
-182
-6% -$61.2K
AXS icon
467
AXIS Capital
AXS
$8.59B
$1.05M 0.07%
10,396
-2,875
-22% -$295K
KYMR icon
468
Kymera Therapeutics
KYMR
$9.1B
$1.05M 0.07%
+12,657
New +$1M
ACMR icon
469
ACM Research
ACMR
$5.83B
$1.05M 0.07%
+26,759
New +$1.42M
NX icon
470
Quanex
NX
$854M
$1.05M 0.07%
58,623
-37,456
-39% -$707K
TROW icon
471
T. Rowe Price
TROW
$25B
$1.05M 0.07%
11,656
+4,711
+68% +$456K
PNW icon
472
Pinnacle West Capital
PNW
$12.9B
$1.05M 0.07%
10,407
+6,312
+154% +$609K
FULC icon
473
Fulcrum Therapeutics
FULC
$248M
$1.05M 0.07%
136,664
+36,955
+37% +$343K
CNO icon
474
CNO Financial Group
CNO
$4.97B
$1.05M 0.07%
+25,505
New +$1.07M
KRP icon
475
Kimbell Royalty Partners
KRP
$1.47B
$1.05M 0.07%
72,253
+29,170
+68% +$399K
17 18
19
20 21

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
RC
Roundview Capital Princeton, New Jersey $1.61B AUM 16.92% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
PPW
Parcion Private Wealth Bellevue, Washington $1.61B AUM 31.08% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return

GSA Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, GSA Capital Partners held 2,259 positions worth $1.61B, up 39% from $1.16B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GSA Capital Partners deployed $533M of net new capital in Q1 2026, opening 642 new positions and adding to 549 existing holdings. Its largest new stake was Vanguard Intermediate-Term Corporate Bond ETF: 389,989 shares worth $32.3M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was NVIDIA, an estimated $4.12M trimmed.

  • GSA Capital Partners's largest Q1 2026 buy was Vanguard Intermediate-Term Corporate Bond ETF: 389,989 shares worth $32.3M.
  • GSA Capital Partners added most to Vanguard Short-Term Corporate Bond ETF in Q1 2026, an estimated $39.8M increase.
  • GSA Capital Partners's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $4.12M.
  • GSA Capital Partners fully exited EOG Resources in Q1 2026, selling an estimated $4.13M.
  • GSA Capital Partners's ten largest holdings make up 12% of its $1.61B portfolio in Q1 2026.
  • GSA Capital Partners opened 642 new positions and closed 595 in Q1 2026.
  • GSA Capital Partners's portfolio value rose 39% quarter-over-quarter to $1.61B.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.